Pfizer to sell vaccine to poor countries
This article was originally published in Scrip
Executive Summary
In a relief effort aimed at getting children much-need medicine, Pfizer said it will sell as many as 740 million doses of its blockbuster pneumonia vaccine for a fraction of the product’s price to poor countries.